Overview

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

Status:
Enrolling by invitation

Trial end date:
2021-07-01

Target enrollment:

Participant gender:

Summary

This is a pilot randomized controlled trial aimed to evaluate the effect of teriparatide on the clinical course of hypocalcemia after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients.

Phase:

Phase 3

Details

Lead Sponsor:

Saint Petersburg State University, Russia

Treatments:

Teriparatide